Article
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.
FOCIS Centre for Clinical Immunology and Immunotherapeutics, Robarts Research Institute, London, Ontario, Canada.
Nature medicine (impact factor:
27.14).
07/2009;
15(6):641-8.
DOI:10.1038/nm.1965
pp.641-8
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
bacteria
cause massive T cell activation
downregulatory effect
human interleukin-2 response
infections
mouse models
peptidoglycan-embedded molecules binding
simultaneous administration
simultaneous presence
staphylococcal enterotoxin B
staphylococcal strains
Staphylococcal superantigens
Staphylococcus aureus peptidoglycan
strong adaptive immune response induced
substantial prevention
superantigen-induced toxic shock syndrome
T cell response
Toll-like receptor 2
toxic shock syndrome
toxins